Hints and tips:
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...Xerox wants to give HP’s board its walking papers We’re all guilty of overusing the David v Goliath trope but in the case of Xerox and HP, it really does apply....
...Changes to the rules — introduced in 2011 — contributed to a speedy outline takeover agreement between brewers AB InBev and SABMiller, its £68bn target....
...Among the largest of these were the blockbuster tie-ups between drugmakers Pfizer and Allergan, brewers AB InBev and SABMiller and oil majors Royal Dutch Shell and BG Group....
...SAB alone added 22 points to the index, rising 19.9 per cent to £36.14, after the brewer confirmed speculation that it had been approached by AB InBev about making a $275bn takeover offer....
...Investors quickly sold the shares of Japan’s biggest brewer on news of the pricey offer....
...The possibility of a Pfizer/AstraZeneca deal still has the politicians talking (the chief executives of both were hauled before the UK parliament this week)....
...on.ft.com/VmUYdX Bad Chinese weather curbs SABMiller lager Unusually cold and wet weather in China has been blamed for weaker than expected quarterly volume growth at SABMiller, the world’s second biggest brewer...
...beyondbrics India v China: a new race in biopharmaceuticals, beyondbrics...
...So has the independence of that country’s entire pharmaceutical sector, with Pharmacia absorbed by Pfizer of the US and Astra merged into AstraZeneca, based in the UK....
...In drugmakers, Pfizer rose 1.1 per cent to $16.10 after a study said patients should stick with Pfizer’s cholesterol-lowering drug Lipitor rather than switching to a generic alternative....
...The ministry has previously extracted promises from Anheuser-Busch not to increase shareholdings in four Chinese brewers during its global takeover of Inbev and ordered Japan’s Panasonic to divest factories...
...Pfizer, the largest US drugmaker by market value, inched down 0.7 per cent to $14.54 as the stock being removed from the “conviction buy” list at Goldman Sachs....
...- Mr V and Mr O review Hix, Brewer Street, Soho. - What might you learn in Afren’s annual report? - Musings on Mishkin. Need to know the news first thing?...
...In November 2008 the ministry cleared Belgium-based InBev’s $52bn acquisition of Anheuser-Busch, the US brewer, but imposed restrictions to stop InBev acquiring further interests in four China companies....
...Last week’s US jobs report has knocked investor confidence, and those predicting a V-shaped recovery are finding it harder to justify their positions....
...This spurred groups such as Pfizer of the US and Roche of Switzerland to strike multi-billion-dollar deals during the first half of this year....
...The Belgian brewer secured a $45bn debt package from 10 banks which included a $7bn bridge loan....
...Belgian-Brazilian brewer InBev is turning up the heat on its unsolicited $46bn takeover bid to buy US rival Anheuser-Busch....
...The Financial Times reported in April that Diageo had considered buying brewer Scottish & Newcastle with SABMiller....
...Kindler, Chairman and CEO, Pfizer Inc., USA Klaus Kleinfeld, President and CEO, Siemens AG, Germany Mustafa V....
...The broker said the worries over the impact on earnings of Pfizer’s Exubra, an inhaled insulin treatment, were overdone....
International Edition